Charles-Briac Levaché

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Jean‐François Emile, Catherine Julié, Karine Le Malicot et al. · European Journal of Cancer · 2017 · 45 citations · Full text

Prognostic Biomarkers, Gastrointestinal Oncology, Medicine +9

Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

Roberto Sorio, C. Roemer-Bécuwe, Felix Hilpert et al. · Gynecologic Oncology · 2016 · 27 citations

Oncology, Elderly Patients, Metronomic Therapy +9

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for <i>RAS</i> Wild-Type Metastatic Colorectal Cancer

Valérie Boige, Hélène Blons, Éric François et al. · JAMA Network Open · 2023 · 18 citations · Full text

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer

Adrien Grancher, Ludivine Beaussire, Sylvain Manfrédi et al. · Frontiers in Oncology · 2022 · 14 citations · Full text